钙离子拮抗剂治疗动脉粥样硬化的现状.pdf

· · 1372 实用医药杂志 年 月第 卷第 期 200711 24 11 7 WoodsideKJ,Townsend CMJr,Mark EversB.Current manage- ment of gastrointestinal carcinoid tumors. J Gastrointest Surg, 2004,8(6):742. 2002,82(1):19. 8 ReisineT,Bell GI.Molecularpropertiesofsomatostatinreceptors. Neuroscience,1995,67(4):777. 9 CordelierP,EsteveJP,Bousquet C,et al.Characterization ofthe antiproliferative signal meditated by the somatostatin receptor 1401. 丁 锐张群华倪泉兴 生长抑素对人胰腺癌细胞增殖作用的实 , , . subtypeSSTR5.ProcNatl AcadSci USA,1997,94(17):9343. 22 验研究.肝胆外科杂志,2004,12(2):146. 10 CharlandS,BoucherMJ,HoudeM,et al.SomatostatininhibitsAkt phosphorylation and cycleentry,but not p42/p44mitogen-acti- vated protein(MAP) kinase avtivation in normal and tomoral : 121. pancreaticcells.Endocrinol,2001,142(1) 11 Berruti A, Dogliotti L,Mosca A,et al.Effects ofthe somatostatin analoguelanreotideon the circulatinglevels ofchomogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advancedprostatecancerpatients.Prostate,2001,47(3):205. 12 WolteringEA,Watson JC,Alperin-LeaRC,et al.Somatostatin ,2000,16(6):1197. analogues: Angiogenesis inhibitors with novel mechanisms of vitroand in vivo.Int JOncol action.Invest NewDrugs,1997,15(1):77. 13 Denzler B, Reubi JC. Expression of somatostatin receptors in ramacol Sin,2004,25(10):1380. peritumoral veinsofhuman tumors.Cancer,1999,85(1):188. 14 Sharma K, Srikant CB. Induction ofwild 2type p53, Bax, and acidic endonuclease duri